慢性HBV感染者病毒特异性T淋巴细胞：耗竭还是沉默？

王昊亮; 邓国宏

doi:10.3969/j.issn.1001-5256.2020.05.005

慢性HBV感染者病毒特异性T淋巴细胞：耗竭还是沉默？

DOI: 10.3969/j.issn.1001-5256.2020.05.005

陆军军医大学西南医院感染病科，感染病研究重庆市重点实验室

基金项目:

传染病国家科技重大专项（2018ZX10302206）；国家自然科学基金重点项目（81930061）；重庆市自然科学基金（cstc2019jcyj-zdxmX0004,cstc2019jcyj-bshX0039）；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 967
- HTML全文浏览量: 42
- PDF下载量: 235
- 被引次数: 0
出版历程
- 出版日期: 2020-05-20

Functional status of hepatitis B virus-specific T cells in patients with chronic hepatitis B virus infection:Exhausted or silenced?

Chongqing Key Laboratory of Infectious Diseases, Department of Infectious Diseases, Southwest Hospital of Army Medical University, Chongqing 400038, China

Research funding:

摘要

摘要:
当前主流观点认为,慢性HBV感染者的病毒特异性T淋巴细胞是处于耗竭状态的T淋巴细胞。总结了以往研究支持该假说的证据,同时对于该假说与临床观察不一致之处提出相应的疑问。综合近期研究结果,认为慢性HBV感染者的病毒特异性T淋巴细胞很可能是分化早期的前体T淋巴细胞占主导,功能上处于沉默而非耗竭状态,并分析了该群T淋巴细胞保持沉默静息状态的可能原因。
- 乙型肝炎病毒 /
- 乙型肝炎,慢性 /
- T淋巴细胞 /
- 免疫耐受
Abstract:
Hepatitis B virus(HBV)-specific T cells in patients with chronic HBV infection are currently acknowledged as exhausted T cells. This article summarizes previous studies which support this hypothesis and then points out several inconsistencies between this hypothesis and clinical observation. Based on recent research findings, it is pointed out that in patients with chronic HBV infection, HBV-specific T cells might be dominated by silenced, early-differentiated progenitor T cells. Also, this article analyzes the possible causes of the silenced status of those T cells.
- hepatitis B virus /
- hepatitis B,chronic /
- T-lymphocytes /
- immune tolerance

HTML全文

参考文献(31)

[1] LIAW YF, CHU CM. Immune tolerance phase of chronic hepatitis B[J]. Gastroenterology, 2017, 152(5):1245-1246.

[2] PENNA A, ARTINI M, CAVALLI A, et al. Long-lasting memory T cell responses following self-limited acute hepatitis B[J]. J Clin Invest, 1996, 98(5):1185-1194.

[3] REHERMANN B, FOWLER P, SIDNEY J, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis[J]. J Exp Med,1995, 181(3):1047-1058.

[4] FERRARI C, PENNA A, BERTOLETTI A, et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection[J]. J Immunol,1990, 145(10):3442-3449.

[5] THIMME R, WIELAND S, STEIGER C, et al. CD8(+)T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection[J]. J Virol, 2003, 77(1):68-76.

[6] BONI C, FISICARO P, VALDATTA C, et al. Characterization of hepatitis B virus(HBV)-specific T-cell dysfunction in chronic HBV infection[J]. J Virol, 2007, 81(8):4215-4225.

[7] BENGSCH B, MARTIN B, THIMME R. Restoration of HBVspecific CD8+T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation[J]. J Hepatol,2014, 61(6):1212-1219.

[8] SCHURICH A, KHANNA P, LOPES AR, et al. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection[J]. Hepatology, 2011, 53(5):1494-1503.

[9] LOPES AR, KELLAM P, DAS A, et al. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection[J]. J Clin Invest, 2008, 118(5):1835-1845.

[10] PARK JJ, WONG DK, WAHED AS, et al. Hepatitis B virusspecific and global T-cell dysfunction in chronic hepatitis B[J]. Gastroenterology, 2016, 150(3):684-695. e5.

[11] WHERRY EJ. T cell exhaustion[J]. Nature Immunol, 2011,12:492-499.

[12] MUELLER SN, AHMED R. High antigen levels are the cause of T cell exhaustion during chronic viral infection[J]. Proc Natl Acad Sci U S A, 2009, 106(21):8623-8628.

[13] KENNEDY P, SANDALOVA E, JO J, et al. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B[J]. Gastroenterology, 2012, 143(3):637-645.

[14] WHERRY EJ, BLATTMAN JN, MURALI-KRISHNA K, et al.Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment[J]. J Virol, 2003, 77(8):4911-4927.

[15] BROOKS DG, TEYTON L, OLDSTONE MB, et al. Intrinsic functional dysregulation of CD4 T cells occurs rapidly fol owing persistent viral infection[J]. J Virol, 2005, 79(16):10514-10527.

[16] RIVINO L, LE BERT N, GILL US, et al. Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation[J]. J Clin Invest, 2018, 128(2):668-681.

[17] RINKER F, ZIMMER CL, HÖNER ZU SIEDERDISSEN C, et al.Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B[J]. J Hepatol, 2018, 69(3):584-593.

[18] TSAI SL, CHEN PJ, LAI MY, et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion[J]. J Clin Invest, 1992,89(1):87-96.

[19] WANG H, LUO H, WAN X, et al. TNF-α/IFN-γprofile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection[J]. J Hepatol, 2020,72(1):45-56.

[20] VERDON D, BROOKS A, GAGGAR A, et al. Immunological assessment of HBeAg-negative chronic hepatitis B patient responses following anti-PD-1 treatment[J]. Hepatology,2017, 66:23A.

[21] CAO Z, LIU Y, MA L, et al. A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alpha[J]. Hepatology, 2017, 66(4):1058-1066.

[22] IM SJ, HASHIMOTO M, GERNER MY, et al. Defining CD8+T cells that provide the proliferative burst after PD-1 therapy[J]. Nature, 2016, 537(7620):417-421.

[23] JANSEN CS, PROKHNEVSKA N, MASTER VA, et al. An intratumoral niche maintains and differentiates stem-like CD8 T cel s[J]. Nature, 2019, 576(7787):465-470.

[24] KURKTSCHIEV PD, RAZIORROUH B, SCHRAUT W, et al.Dysfunctional CD8+T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction[J]. J Exp Med, 2014, 211(10):2047-2059.

[25] CRAWFORD A, ANGELOSANTO JM, KAO C, et al. Molecular and transcriptional basis of CD4+T cell dysfunction during chronic infection[J]. Immunity, 2014, 40(2):289-302.

[26] WU JQ, SEAY M, SCHULZ VP, et al. Tcf7 is an important regulator of the switch of self-renewal and differentiation in a multipotential hematopoietic cell line[J]. PLoS Genet, 2012,8(3):e1002565.

[27] ZHOU X, YU S, ZHAO DM, et al. Differentiation and persistence of memory CD8(+)T cells depend on T cell factor 1[J]. Immunity, 2010, 33(2):229-240.

[28] SUSLOV A, BOLDANOVA T, WANG X, et al. Hepatitis B virus does not interfere with innate immune responses in the human liver[J]. Gastroenterology, 2018, 154(6):1778-1790.

[29] VYAS AK, JINDAL A, TREHANPATI N. Ponder the innate immunity in hepatitis B infection[J]. Gastroenterology, 2018,155(4):1277.

[30] TAN AT, KOH S, GOH W, et al. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B[J]. J Hepatol, 2010, 52(3):330-339.

[31] JACOBI FJ, WILD K, SMITS M, et al. OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4T cells in patients with HBeAg-negative infection[J]. J Hepatol, 2019, 70(6):1103-1113.

施引文献

资源附件(0)

访问统计